<DOC>
	<DOCNO>NCT00639652</DOCNO>
	<brief_summary>Currently , conduct prospective , randomized trial compare outcome surgical excision outcome curettage nodular superficial BCCs . Larger BCCs micronodular sclerosing BCCs include randomize study . They mainly operate use three-dimensional histology ( 3D-histology , micrographic surgery ) . In observational study measure cosmetic result recurrence rate BCCs include randomize trial .</brief_summary>
	<brief_title>Recurrence Rate Esthetic Outcome After Excision Basal Cell Carcinomas Excluded From Trial NCT00515970</brief_title>
	<detailed_description>1 . Disinfection 2 . Local anesthesia 3 . Surgery 4 . Dressing 5 . Preparation paraffin histopathologic evaluation 6 . Staining hematoxylin-eosin 7 . Adjuvant radiotherapy apply patient . 8 . If histopathology discovers another tumor BCC , tumor exclude . 9 . If recurrence suspect , punch biopsy take . If recurrence confirm , endpoint achieve . 10 . Patients provide feedback receive phone call . 11 . The patient receives letter contain list BCCs treat within study . She ask visit private practitioner list 12 48 month ( +/- 30 day ) refer last operation recruitment period . The practitioner patient return questionnaire department . 12 . The letter contain questionnaire suspicion recurrence BCC . 13 . The patient ask assess esthetic outcome scale excellent , good , satisfactory , mediocre , poor . 14 . The physician ask assess esthetic outcome scale excellent , good , satisfactory , mediocre , poor . 15 . When follow-up close individual patient , reason record : 1 . Planned end follow-up 48 month 2 . Patient move . 3 . Death ( date death ) 4 . Consent withdraw 5 . Meanwhile , patient become ill high-maintenance follow-up visit plan . 6 . Recurrence patient 's BCCs histopathologic confirmation .</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Recurrence</mesh_term>
	<mesh_term>Carcinoma , Basal Cell</mesh_term>
	<criteria>BCCs exclude randomize trial NCT00515970 Treatment 3Dhistology shave excision ( e.g . deep surgical excision without 3Dhistology )</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2008</verification_date>
	<keyword>Carcinoma , Basal Cell</keyword>
	<keyword>3D-histology</keyword>
	<keyword>Micrographic surgery</keyword>
	<keyword>Mohs surgery</keyword>
	<keyword>Shave excision</keyword>
	<keyword>Recurrence</keyword>
	<keyword>Esthetic outcome</keyword>
</DOC>